Insider · CIK 0001792746

Pasternak Andy

Reports to the SEC for 3 companies · PHILADELPHIA, PA

sec.gov

Transactions

Companies

Filings

CIK

0001792746

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-24	CNTXContext Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2026-06-17	KARDKardigan, Inc.A Award	Chief Strategy Officer	AAward	+79.6K sh	—	—	79,640
2025-06-12	CNTXContext Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+139K sh	—	—	138,900
2025-01-13	CNTXContext Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+20.7K sh	—	—	20,685
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	EVP, Chief Strategy Officer	DDisposition to Issuer	−56.3K sh	$116.50	−$6.56M	0
2023-10-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	EVP, Chief Strategy Officer	DDisposition to Issuer	−11.6K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	EVP, Chief Strategy Officer	DDisposition to Issuer	−15.9K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	EVP, Chief Strategy Officer	DDisposition to Issuer	−23K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Chief Strategy Officer	DDisposition to Issuer	−15.3K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Chief Strategy Officer	DDisposition to Issuer	−5,816 sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Chief Strategy Officer	DDisposition to Issuer	−34.9K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Chief Strategy Officer	DDisposition to Issuer	−4,761 sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Chief Strategy Officer	DDisposition to Issuer	−14.3K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Chief Strategy Officer	DDisposition to Issuer	−23.8K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Chief Strategy Officer	DDisposition to Issuer	−11.5K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Chief Strategy Officer	DDisposition to Issuer	−5,749 sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Chief Strategy Officer	DDisposition to Issuer	−5,749 sh	—	—	0
2023-01-17	Horizon Therapeutics Public Ltd CoS Sale	EVP, Chief Strategy Officer	SSale	−27.1K sh	$113.03	−$3.07M	56,338
2023-01-04	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)A Award	EVP, Chief Strategy Officer	AAward	+23K sh	—	—	22,997
2022-12-30	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+88.7K sh	—	—	122,780
2022-12-30	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP, Chief Strategy Officer	FTax Payment	−39.3K sh	$113.80	−$4.47M	83,467
2022-12-30	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSU)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−8,709 sh	—	—	0
2022-12-30	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSU)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−2,360 sh	—	—	0
2022-12-30	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSU)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−5,800 sh	—	—	0
2022-12-30	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSU)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−26.1K sh	—	—	0
2022-12-30	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSU)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−11.6K sh	—	—	5,816
2022-12-30	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−14.5K sh	—	—	0
2022-12-30	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−11.6K sh	—	—	11,643
2022-12-30	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−7,935 sh	—	—	15,870
2022-12-27	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)A Award	EVP, Chief Strategy Officer	AAward	+26.1K sh	—	—	26,124
2022-12-27	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)A Award	EVP, Chief Strategy Officer	AAward	+17.5K sh	—	—	17,464
2022-12-13	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+23.3K sh	$29.52	+$686K	64,216
2022-12-13	Horizon Therapeutics Public Ltd CoS Sale	EVP, Chief Strategy Officer	SSale	−23.3K sh	$112.61	−$2.62M	40,965
2022-12-13	Horizon Therapeutics Public Ltd CoS Sale	EVP, Chief Strategy Officer	SSale	−6,918 sh	$112.60	−$779K	34,047
2022-12-13	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−23.3K sh	—	—	0
2022-11-01	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+12.4K sh	—	—	46,468
2022-11-01	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP, Chief Strategy Officer	FTax Payment	−5,503 sh	$63.18	−$348K	40,965
2022-11-01	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+12.4K sh	—	—	0
2022-07-29	Horizon Therapeutics Public Ltd CoS Sale	EVP, Chief Strategy Officer	SSale	−4,207 sh	$82.44	−$347K	34,690
2022-07-29	Horizon Therapeutics Public Ltd CoS Sale	EVP, Chief Strategy Officer	SSale	−643 sh	$83.45	−$53.7K	34,047
2022-06-10	Horizon Therapeutics Public Ltd CoS Sale	EVP, Chief Strategy Officer	SSale	−762 sh	$85.36	−$65K	38,897
2022-02-18	Horizon Therapeutics Public Ltd CoS Sale	EVP, Chief Strategy Officer	SSale	−1,313 sh	$94.82	−$124K	39,659
2022-01-06	Horizon Therapeutics Public Ltd CoS Sale	EVP, Chief Strategy Officer	SSale	−500 sh	$97.30	−$48.7K	48,459
2022-01-06	Horizon Therapeutics Public Ltd CoS Sale	EVP, Chief Strategy Officer	SSale	−700 sh	$98.33	−$68.8K	47,759
2022-01-06	Horizon Therapeutics Public Ltd CoS Sale	EVP, Chief Strategy Officer	SSale	−6,438 sh	$99.85	−$643K	41,321
2022-01-06	Horizon Therapeutics Public Ltd CoS Sale	EVP, Chief Strategy Officer	SSale	−349 sh	$100.23	−$35K	40,972
2022-01-05	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	+48.8K sh	—	—	70,669
2022-01-05	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP, Chief Strategy Officer	FTax Payment	−21.7K sh	$101.84	−$2.21M	48,959
2022-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−14.5K sh	—	—	14,514
2022-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP, Chief Strategy Officer	MExercise/Conversion	−11.6K sh	—	—	23,286

Recent filings

Accepted (ET)
Jun 264
Pasternak Andy0001628280-26-045789
SEC(opens sec.gov)
Jun 224
Pasternak Andy0001193125-26-277955
SEC(opens sec.gov)
Jun 124
Pasternak Andy0001842952-25-000078
SEC(opens sec.gov)
Jan 144
Pasternak Andy0001842952-25-000010
SEC(opens sec.gov)
Oct 64
Pasternak Andy0001209191-23-052364
SEC(opens sec.gov)
Jan 184
Pasternak Andy0001209191-23-003733
SEC(opens sec.gov)
Jan 64
Pasternak Andy0001209191-23-002432
SEC(opens sec.gov)
Jan 44
Pasternak Andy0001209191-23-000879
SEC(opens sec.gov)

Companies

Address

2001 MARKET STREET SUITE 3915 UNIT #15

PHILADELPHIA, PA, 19103